Prolactinoma Market: How Is Dopamine Agonist Therapy Becoming the Fastest-Growing Treatment Modality?
Dopamine agonist pharmacotherapy — the medical management approach using cabergoline and bromocriptine to suppress prolactin secretion and shrink prolactin-secreting pituitary adenomas representing the first-line treatment standard — creates the most commercially dynamic market segment, with the Prolactinoma Market reflecting dopamine agonist therapy as the premium growth commercial...
0 Commenti 0 condivisioni 26 Views 0 Anteprima